Abstract
Interleukin-15 shares many biological activities with IL-2 and signals through the IL-2 receptor β and γ chains1–3. However, IL-15 and IL-2 differ in their controls of expression and secretion, their range of target cells and their functional activities3–7. These dissimilarities may include differential effects on apoptosis. For example, IL-2 induces or inhibits T-cell apoptosis in vitro, depending on T-cell activation8, whereas IL-15 inhibits cytokine deprivation-induced apoptosis in activated T cells9. Studying whether and how IL-15 modulates distinct apoptosis pathways10–12, we show here that apoptosis induced by anti-Fas, anti-CD3, dexamethasone, and/or anti-IgM in activated human T and B cells in vitro is inhibited by IL-15 in a manner dependent on RNA synthesis. In vivo, anti-Fas-induced lethal multisystem apoptosis in mice is suppressed by a novel IL-15–lgG2b fusion protein. Only IL-15, but not IL-2, completely protected from lethal hepatic failure. Thus, IL-15 is a potent, general inhibitor of apoptosis in vitro and in vivo with intriguing therapeutic potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grabstein, K.H. et al. Cloning of a T cell growth factor that interacts with the b chain of the interleukin-2 receptor. Science 264, 965–968 (1994).
Giri, J.G. et al. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822–2830 (1994).
Tagaya, Y., Bamford, R.N., DeFilippis, A.P. & Waldmann, T.A. IL 15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329–336 (1996).
Onu, A., Pohl, T., Krause, H. & Bulfone-Paus, S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158, 255–262 (1997).
Giri, J.G. et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14, 3654–3663 (1995).
Bulfone-Paus, S. et al. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 9, 507–513 (1997).
Taniguchi, T. & Minami, Y. The IL-2/IL-2 Receptor system: A current overview. Cell 73, 5–8 (1993).
Lenardo, M.J. Interleukin-2 programs mouse ab T lymphocytes for apoptosis. Nature 353, 858–861 (1991).
Akbar, A.N. et al. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of antiapoptotic (bcl-2, bcl x.) but not pro-apoptotic (bax, bcl-x5) gene expression. Eur. J. Immunol. 26, 294–299 (1996).
Nagata, S. & Golstein, P. The FAS death factor. Science 267, 1449–1456 (1995).
White, E., Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1–15 (1996).
Cotter, T.G. & Martin, S.J. eds. Techniques in Apoptosis. (Portland, London, 1996).
Watanabe, D.T., Suda, T. & Nagata, S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7, 1949–1955 (1995).
Scott, D.W., Grdina, T. & Shi, Y. T cells commit suicide, but B cells are murdered! J.Immunol. 156, 2352–2356 (1996).
Dhein, J. et al. Autocrine T-cell suicide by APO-1 /(Fas/CD95). Nature 373, 438–440 (1995).
Wesselborg, S., Janssen, O. & Kabeiitz, D. Induction of activation driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150, 4338–4345 (1993).
Ogasawara, B.J., Suda, T. & Nagata, S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J. Exp. Med. 181, 485–491 (1995).
Cohen, J.J. & Duke, R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132, 38–42 (1984).
Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
Lacronique, V. et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med. 2, 80–86 (1996).
Ashkenazi, A. & Chamow, S.M. Immunoadhesins as research tools and therapeutic agents. Curr. Opin. Immunol. 9, 195–200 (1997).
Kunzendorf, U. et al. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice. J. clin. Invest. 97, 1204–1210 (1996).
Willerford, D.M. et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 (1995).
Coligan, J.E. et al., eds. Current Protocols in Immunology. (Wiley & Sons, New York, 1994).
Smith, C.A. et al. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181–183 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bulfone-Paus, S., Ungureanu, D., Pohl, T. et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 3, 1124–1128 (1997). https://doi.org/10.1038/nm1097-1124
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1097-1124